Novus Biologicals™ Cyr61/CCN1 Antibody (Roche patent anti-CCN1) - Humanized, Novus Biologicals™
Human Monoclonal Antibody
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Antigen
Cyr61/CCN1
Applications
Flow Cytometry, ELISA, Functional Assay
Conjugate
Unconjugated
Host Species
Human
Research Discipline
Biologically Active Proteins
Formulation
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias
CCN family member 1, CCN1IGF-binding protein 10, Cysteine-rich angiogenic inducer 61, cysteine-rich, angiogenic inducer, 61, GIG1cysteine-rich heparin-binding protein 61, IBP-10, IGFBP-10, IGFBP10cysteine-rich, anigogenic inducer, 61, Insulin-like growth factor-binding protein 10, protein CYR61, Protein GIG1
Immunogen
CYR61/ CCN1
Primary or Secondary
Primary
Reconstitution
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Clone
Roche patent anti-CCN1
Classification
Monoclonal
Form
Purified
Regulatory Status
RUO
Target Species
Human
Gene Accession No.
O00622
Gene ID (Entrez)
3491
Isotype
IgG1
Purification Method
Protein A purified
Content And Storage
Store at -20°C in powder form. Store at -80°C once reconstituted.
Related Products
Description
- Cyr61/CCN1 Monoclonal antibody specifically detects Cyr61/CCN1 in Human samples
- It is validated for Flow Cytometry,ELISA,Functional Assay